Actively Recruiting
Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study
Led by Beijing Friendship Hospital · Updated on 2025-02-13
180
Participants Needed
1
Research Sites
304 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to investigate the effect of sacubitril/valsartan on cardiac function assessed by cardiac magnetic resonance (CMR) in hypertensive patients stratified by BMI.
CONDITIONS
Official Title
Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with essential hypertension
- Age between 18 and 70 years
- Able to provide written consent without major barriers
You will not qualify if you...
- Secondary hypertension except when caused by sleep apnea
- Cardiovascular events (heart attack, heart failure, stroke, or coronary procedures) within the past 6 months
- Severe diseases such as autoimmune disorders, cancer, late-stage liver disease, respiratory or digestive diseases
- Inability to understand or follow study procedures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100050
Actively Recruiting
Research Team
R
Rongchong Huang, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here